Asa and Oesophageal carcinoma - a phase IV clinical study of FDA data
Oesophageal carcinoma is found among people who take Asa, especially for people who are male, 60+ old.
The phase IV clinical study analyzes which people take Asa and have Oesophageal carcinoma. It is created by eHealthMe based on reports of 31,999 people who have side effects when taking Asa from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
31,999 people reported to have side effects when taking Asa.
Among them, 17 people (0.05%) have Oesophageal carcinoma.
What is Asa?
Asa has active ingredients of aspirin. It is often used in blood clots. eHealthMe is studying from 32,515 Asa users for its effectiveness, alternative drugs and more.
What is Oesophageal carcinoma?
Oesophageal carcinoma (cancer tumour of oesophagus) is found to be associated with 754 drugs and 388 conditions by eHealthMe.
Number of Asa and Oesophageal carcinoma reports submitted per year:
Gender of people who have Oesophageal carcinoma when taking Asa *:
- female: 14.29 %
- male: 85.71 %
Age of people who have Oesophageal carcinoma when taking Asa *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 10 %
- 60+: 90 %
Common drugs people take besides Asa *:
- Gravol: 6 people, 35.29%
- Benadryl: 6 people, 35.29%
- Xarelto: 6 people, 35.29%
- Norvasc: 6 people, 35.29%
- Solu-Medrol: 4 people, 23.53%
- Inflectra: 3 people, 17.65%
- Crestor: 3 people, 17.65%
- Esbriet: 3 people, 17.65%
- Lyrica: 3 people, 17.65%
- Lipitor: 2 people, 11.76%
Common side effects people have besides Oesophageal carcinoma *:
- Heart Rate Irregular: 6 people, 35.29%
- Blood Pressure Fluctuation: 6 people, 35.29%
- Cancer - Throat Or Larynx: 6 people, 35.29%
- Heart Rate Decreased: 6 people, 35.29%
- Death: 3 people, 17.65%
- Malaise (a feeling of general discomfort or uneasiness): 3 people, 17.65%
- Swallowing Difficulty: 2 people, 11.76%
- Weakness: 1 person, 5.88%
- Adenocarcinoma (malignant tumour formed from glandular structures in epithelial tissue): 1 person, 5.88%
- Arteriosclerosis Coronary Artery (thickening and hardening of arteries- coronary artery): 1 person, 5.88%
Common conditions people have *:
- Ankylosing Spondylitis (type of arthritis affecting the spine): 6 people, 35.29%
- Coronary Heart Disease (narrowing or blockage of the coronary arteries): 3 people, 17.65%
- Idiopathic Pulmonary Fibrosis (chronic lung disease): 3 people, 17.65%
- Gout (uric acid crystals building up in the body): 1 person, 5.88%
- Back Pain: 1 person, 5.88%
- Blood Glucose Fluctuation: 1 person, 5.88%
- Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 1 person, 5.88%
- Diabetes: 1 person, 5.88%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.88%
- Psoriasis (immune-mediated disease that affects the skin): 1 person, 5.88%
* Approximation only. Some reports may have incomplete information.
Do you take Asa and have Oesophageal carcinoma?Check whether Oesophageal carcinoma is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Alokaily FA, Alghamdi M, Almalki AS, Alhussaini H, "Aspirin induced leukocytoclastic vasculitis, lower gastrointestinal hemorrhage and acute renal failure (mimicking systemic vasculitis)", Saudi medical journal, 2013 Apr .
How severe was Oesophageal carcinoma and when was it recovered:
Expand to all the drugs that have ingredients of aspirin:
Alternative drugs to, pros and cons of Asa:
- Asa (32,515 reports)
Common Asa side effects:
- Fatigue (feeling of tiredness): 2,775 reports
- Breathing difficulty: 2,198 reports
- Diarrhea: 2,102 reports
- Weakness: 1,960 reports
- Drug ineffective: 1,876 reports
- High blood pressure: 1,849 reports
- Dizziness: 1,799 reports
- Headache (pain in head): 1,705 reports
- Pain: 1,628 reports
Browse all side effects of Asa:a b c d e f g h i j k l m n o p q r s t u v w x y z
Oesophageal carcinoma treatments and more:
- Oesophageal carcinoma (33,075 reports)
COVID vaccines that are related to Oesophageal carcinoma:
- Oesophageal carcinoma in Moderna COVID Vaccine
- Oesophageal carcinoma in Pfizer BioNTech Covid Vaccine
- Oesophageal carcinoma in Johnson and Johnson Covid Vaccine
Common drugs associated with Oesophageal carcinoma:
- Zantac: 18,962 reports
- Ranitidine: 8,936 reports
- Nexium: 245 reports
- Omeprazole: 199 reports
- Prednisolone: 172 reports
- Methotrexate: 170 reports
- Prednisone: 162 reports
- Humira: 148 reports
- Clozaril: 136 reports
- Enbrel: 125 reports
All the drugs that are associated with Oesophageal carcinoma:
- Oesophageal carcinoma (754 drugs)
Common conditions associated with Oesophageal carcinoma:
- Indigestion: 15,098 reports
- Gastric ulcer: 1,508 reports
- Rheumatoid arthritis: 271 reports
- Multiple sclerosis: 175 reports
- High blood pressure: 171 reports
- Osteoporosis: 156 reports
All the conditions that are associated with Oesophageal carcinoma:
- Oesophageal carcinoma (388 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on aspirin (the active ingredients of Asa) and Asa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Invega Sustenna and Tumor - now
- Meperidine Hydrochloride vs. Robaxin - 2 seconds ago
- Axid and Periogard drug interaction - 2 seconds ago
- Glyburide and Septic Shock - 5 seconds ago
- Minocycline Hydrochloride and Proctalgia - 8 seconds ago
- Beyaz vs. Quasense - 8 seconds ago
- Prilosec and Macular Fibrosis - 10 seconds ago
- Accuneb and Welchol drug interaction - 12 seconds ago
- Clopidogrel and Kombiglyze Xr drug interaction - 12 seconds ago
- Methadone Hydrochloride vs. Loestrin Fe 1/20 - 14 seconds ago